Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (371-380 of 651) with videos related to

Pageof 66
Sort By:
Antimicrobial Agents and Chemotherapy|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AMLCarolin S Joisten, Sibylle C Mellinghoff, Danila Seidel, et al.
Oncotarget|December 22, 2017
ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemiaCarolina Yaeko Namasu, Christiane Katzerke, Daniela Bräuer-Hartmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
Oncogene|September 13, 2003
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancerPing Ji, Sven Diederichs, Wenbing Wang, et al.
Blood|June 11, 2021
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cuesXiaobing Yu, Leonel Munoz-Sagredo, Karolin Streule, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
International Journal of Molecular Sciences|February 10, 2024
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of CryopreservationGenqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
Blood Advances|February 15, 2024
Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapyHuixiu Han, Lei Wang, Yuntian Ding, et al.
Pageof 66

Showing results (371-380 of 651) with videos related to

Sort By:
Pageof 66
Antimicrobial Agents and Chemotherapy|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AMLCarolin S Joisten, Sibylle C Mellinghoff, Danila Seidel, et al.
Oncotarget|December 22, 2017
ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemiaCarolina Yaeko Namasu, Christiane Katzerke, Daniela Bräuer-Hartmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.
Oncogene|September 13, 2003
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancerPing Ji, Sven Diederichs, Wenbing Wang, et al.
Blood|June 11, 2021
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cuesXiaobing Yu, Leonel Munoz-Sagredo, Karolin Streule, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 11, 2024
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myelomaSarah Schreiner, Natalie Berghaus, Alexandra M Poos, et al.
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
International Journal of Molecular Sciences|February 10, 2024
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of CryopreservationGenqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
Blood Advances|February 15, 2024
Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapyHuixiu Han, Lei Wang, Yuntian Ding, et al.
Pageof 66